Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 141

    1.

    Impaired glucose tolerance and insulin resistance are associated with increased adipose 11beta-hydroxysteroid dehydrogenase type 1 expression and elevated hepatic 5alpha-reductase activity.

    Tomlinson JW, Finney J, Gay C, Hughes BA, Hughes SV, Stewart PM.

    Diabetes. 2008 Oct;57(10):2652-60. Epub 2008 Jul 15.PMID: 18633104 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Reduced glucocorticoid production rate, decreased 5alpha-reductase activity, and adipose tissue insulin sensitization after weight loss.

    Tomlinson JW, Finney J, Hughes BA, Hughes SV, Stewart PM.

    Diabetes. 2008 Jun;57(6):1536-43. Epub 2008 Mar 13.PMID: 18340018 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Altered cortisol metabolism in polycystic ovary syndrome: insulin enhances 5alpha-reduction but not the elevated adrenal steroid production rates.

    Tsilchorozidou T, Honour JW, Conway GS.

    J Clin Endocrinol Metab. 2003 Dec;88(12):5907-13.PMID: 14671189 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver.

    Westerbacka J, Yki-Järvinen H, Vehkavaara S, Häkkinen AM, Andrew R, Wake DJ, Seckl JR, Walker BR.

    J Clin Endocrinol Metab. 2003 Oct;88(10):4924-31.PMID: 14557475 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of peroxisome proliferator-activated receptor-alpha and -gamma agonists on 11beta-hydroxysteroid dehydrogenase type 1 in subcutaneous adipose tissue in men.

    Wake DJ, Stimson RH, Tan GD, Homer NZ, Andrew R, Karpe F, Walker BR.

    J Clin Endocrinol Metab. 2007 May;92(5):1848-56. Epub 2007 Feb 27.PMID: 17327378 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Tissue-specific dysregulation of cortisol metabolism in human obesity.

    Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR.

    J Clin Endocrinol Metab. 2001 Mar;86(3):1418-21.PMID: 11238541 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Cortisol metabolism in human obesity: impaired cortisone-->cortisol conversion in subjects with central adiposity.

    Stewart PM, Boulton A, Kumar S, Clark PM, Shackleton CH.

    J Clin Endocrinol Metab. 1999 Mar;84(3):1022-7.PMID: 10084590 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.

    Rask E, Walker BR, Söderberg S, Livingstone DE, Eliasson M, Johnson O, Andrew R, Olsson T.

    J Clin Endocrinol Metab. 2002 Jul;87(7):3330-6.PMID: 12107245 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.

    Alberti L, Girola A, Gilardini L, Conti A, Cattaldo S, Micheletto G, Invitti C.

    Int J Obes (Lond). 2007 Dec;31(12):1826-31. Epub 2007 Jun 26.PMID: 17593901 [PubMed - indexed for MEDLINE]Related articles

    10.

    11beta-hydroxysteroid dehydrogenase type 1 activity in lean and obese males with type 2 diabetes mellitus.

    Valsamakis G, Anwar A, Tomlinson JW, Shackleton CH, McTernan PG, Chetty R, Wood PJ, Banerjee AK, Holder G, Barnett AH, Stewart PM, Kumar S.

    J Clin Endocrinol Metab. 2004 Sep;89(9):4755-61.PMID: 15356090 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Reduced 11beta-hydroxysteroid dehydrogenase type 1 activity in obese boys.

    Wiegand S, Richardt A, Remer T, Wudy SA, Tomlinson JW, Hughes B, Grüters A, Stewart PM, Strasburger CJ, Quinkler M.

    Eur J Endocrinol. 2007 Sep;157(3):319-24.PMID: 17766714 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.

    Snehalatha C, Ramachandran A, Satyavani K, Latha E, Viswanathan V.

    Diabetes Care. 1998 Jan;21(1):76-9.PMID: 9538973 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Association between regional adipose tissue distribution and both type 2 diabetes and impaired glucose tolerance in elderly men and women.

    Goodpaster BH, Krishnaswami S, Resnick H, Kelley DE, Haggerty C, Harris TB, Schwartz AV, Kritchevsky S, Newman AB.

    Diabetes Care. 2003 Feb;26(2):372-9.PMID: 12547865 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    11beta-Hydroxysteroid dehydrogenase Type 1: genetic polymorphisms are associated with Type 2 diabetes in Pima Indians independently of obesity and expression in adipocyte and muscle.

    Nair S, Lee YH, Lindsay RS, Walker BR, Tataranni PA, Bogardus C, Baier LJ, Permana PA.

    Diabetologia. 2004 Jun;47(6):1088-95. Epub 2004 May 20.PMID: 15156315 [PubMed - indexed for MEDLINE]Related articles

    15.

    Abnormal cortisol metabolism and tissue sensitivity to cortisol in patients with glucose intolerance.

    Andrews RC, Herlihy O, Livingstone DE, Andrew R, Walker BR.

    J Clin Endocrinol Metab. 2002 Dec;87(12):5587-93.PMID: 12466357 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity.

    Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM.

    J Clin Endocrinol Metab. 2002 Dec;87(12):5630-5.PMID: 12466364 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    11beta-hydroxysteroid dehydrogenase type 1 and obesity.

    Morton NM, Seckl JR.

    Front Horm Res. 2008;36:146-64. Review.PMID: 18230901 [PubMed - indexed for MEDLINE]Related articles

    18.

    11beta-hydroxysteroid dehydrogenase 2 activity is elevated in severe obesity and negatively associated with insulin sensitivity.

    Müssig K, Remer T, Haupt A, Gallwitz B, Fritsche A, Häring HU, Maser-Gluth C.

    Obesity (Silver Spring). 2008 Jun;16(6):1256-60. Epub 2008 Apr 10.PMID: 18421276 [PubMed - indexed for MEDLINE]Related articles

    19.

    Omental adipose tissue type 1 11 beta-hydroxysteroid dehydrogenase oxoreductase activity, body fat distribution, and metabolic alterations in women.

    Veilleux A, Rhéaume C, Daris M, Luu-The V, Tchernof A.

    J Clin Endocrinol Metab. 2009 Sep;94(9):3550-7. Epub 2009 Jun 30.PMID: 19567539 [PubMed - indexed for MEDLINE]Related articles

    20.

    In vivo activity of 11beta-hydroxysteroid dehydrogenase type 1 and free fatty acid-induced insulin resistance.

    Mai K, Kullmann V, Bobbert T, Maser-Gluth C, Möhlig M, Bähr V, Pfeiffer AF, Spranger J, Diederich S.

    Clin Endocrinol (Oxf). 2005 Oct;63(4):442-9.PMID: 16181237 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data